Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Elastin synthesis pathway**—also known as **elastogenesis**—refers to the multi-step biological process by which cells produce and assemble elastic fibers, primarily composed of the protein elastin. This process is essential for providing elasticity and resilience to tissues such as skin, lungs, arteries, ligaments, and cartilage[1][2][5]. The key steps include: 1. **Tropoelastin Synthesis:** Cells like fibroblasts and smooth muscle cells synthesize tropoelastin—the soluble precursor protein—in the cytoplasm[3]. 2. **Secretion & Coacervation:** Tropoelastin is secreted into the extracellular space where it self-associates via hydrophobic interactions in a temperature-dependent manner called coacervation[1][3]. 3. **Cross-linking:** The enzyme lysyl oxidase catalyzes oxidative deamination of lysine residues on tropoelastins, enabling covalent cross-links through desmosine and isodesmosine bonds that stabilize mature insoluble elastin fibers[1][4]. 4. **Deposition & Maturation:** Cross-linked aggregates are deposited onto microfibril scaffolds (mainly fibrillin), forming mature elastic fibers that integrate into connective tissue matrices[3]. This hierarchical assembly allows tissues to stretch repeatedly without permanent deformation—a property critical for normal cardiovascular function, lung recoil during breathing, skin flexibility, and more[5]. While individual proteins within this pathway—such as *tropoelastin*, *lysyl oxidase*, or *fibrillin*—can be considered therapeutic targets or biomarkers in specific contexts (for example in fibrotic diseases or vascular disorders), "Elastin synthesis pathway" itself refers broadly to an interconnected set of molecular events rather than a single druggable entity. Therefore: **Is this considered a therapeutic target?** No—the "Elastin synthesis pathway" describes an entire biosynthetic process rather than an individual molecule/receptor/enzyme typically targeted by drugs. **Is there something wrong with this target?** Yes—the term does not refer to one discrete molecular entity but rather encompasses multiple proteins/enzymes/steps involved in elastic fiber formation. For structured data purposes focused on drug targets or receptors/enzymes/etc., it should be flagged as incorrect/inapplicable at this level of specificity[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Elastin synthesis pathway.